Mesenchymal Stem Cells Market to Reach USD 9.08 Billion by 2031, Growing at 12% CAGR
Key Insights
The global mesenchymal stem cells (search) market is projected to grow from USD 5.14 billion in 2026 to USD 9.08 billion by 2031, registering a CAGR of 12.05%.
Market expansion is driven by increasing adoption of stem cell-based therapies, rising prevalence of chronic diseases, and growing demand for personalized medicine.
North America holds the largest market share, while Asia-Pacific emerges as a high-growth region fueled by rising healthcare investments and expanding biotechnology capabilities.
The global mesenchymal stem cells (search) (MSC) market is on a robust growth trajectory, with projections indicating an increase from USD 5.14 billion in 2026 to USD 9.08 billion by 2031, reflecting a compound annual growth rate (CAGR) of 12.05%, according to a new report from Mordor Intelligence.
The market expansion is underpinned by the increasing adoption of stem cell-based therapies and intensifying research efforts aimed at developing advanced regenerative treatment solutions. Rising prevalence of chronic diseases, growing demand for personalized medicine, and ongoing advancements in stem cell processing and manufacturing technologies are converging to accelerate market momentum.
Therapeutic Applications Driving Clinical Interest
Researchers and healthcare organizations are increasingly investigating the therapeutic potential of mesenchymal stem cells (search) across a broad spectrum of indications. Their capacity to differentiate into multiple cell types and support tissue repair has positioned MSCs as a cornerstone of regenerative medicine, tissue engineering, and immune-modulation therapies.
Key areas of clinical investigation include orthopedic disorders, autoimmune diseases, cardiovascular conditions, neurological disorders, and wound healing applications. The growing body of evidence supporting MSC utility in these domains is contributing to expanding clinical interest and investment across the healthcare sector.
The market is further benefiting from increasing clinical trial activity, rising public and private funding for regenerative medicine research, and expanding partnerships between biotechnology companies, academic institutions, and healthcare organizations. Growing interest in developing novel therapies for unmet medical needs is expected to continue supporting market growth throughout the forecast period.
Regional Dynamics
North America represents a significant share of the mesenchymal stem cells (search) market, driven by advanced biotechnology infrastructure, strong research funding, growing clinical trial activity, and increasing adoption of regenerative medicine technologies.
Europe holds a notable position, supported by expanding stem cell research programs, favorable research initiatives, and increasing collaboration among academic institutions, biotechnology companies, and healthcare providers.
Asia-Pacific is emerging as a high-growth region due to rising healthcare investments, expanding biotechnology capabilities, growing regenerative medicine research activities, and increasing awareness regarding advanced therapeutic approaches across countries such as China, India, Japan, and South Korea.
Market Segmentation and Key Players
The MSC market is segmented by products and services — including kits, media and reagents, cells and cell lines, and services — as well as by type (autologous and allogeneic), source (adipose tissue, bone marrow, cord blood, fetal liver, and others), and indication. Major application areas span disease modeling, drug development and discovery, stem cell banking, tissue engineering, and toxicology studies.
Major companies operating in the mesenchymal stem cells (search) market include Lonza Group AG (search), Thermo Fisher Scientific Inc. (search), Merck KGaA, STEMCELL Technologies Inc. (search), and PromoCell GmbH (search). Market participants are investing in advanced cell processing technologies, clinical development programs, and strategic collaborations to strengthen their competitive position.
Soumya Goud, Senior Research Manager at Mordor Intelligence, noted: "The mesenchymal stem cells (search) market continues to reflect evolving research priorities, regulatory developments, and commercialization activity across healthcare ecosystems."
Technology Trends Shaping the Future
Innovations in cell expansion, cryopreservation, and large-scale manufacturing processes are improving production efficiency and supporting broader commercialization of stem cell-based therapies. These advancements are critical to meeting the growing demand for high-quality MSC products across clinical and research settings.
Product innovation, research partnerships, and expansion of regenerative medicine pipelines continue to shape competitive dynamics across the industry, positioning the MSC market for sustained growth through 2031 and beyond.